Related Experiment Video
Updated: Mar 15, 2026
06:32
Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
Published on: January 9, 2019
8.4K
Immunohistochemical biomarkers in ameloblastomas
Alan Motta do Canto1,2, Juliana Rodrigues Rozatto1, Juliana Lucena Schussel3,4
1a Unit of Oral and Maxillofacial Surgery , Santa Casa de São Paulo School of Medical Sciences , São Paulo , Brazil.
Acta Odontologica Scandinavica
|August 31, 2016
Summary
Ameloblastoma, an aggressive odontogenic tumor, presents diagnostic challenges. Immunohistochemical markers aid in diagnosis, prognosis, and developing targeted treatments for this recurrent neoplasia.
Area of Science:
- Oral Pathology
- Oncology
- Biomarkers
Background:
- Ameloblastoma is a locally invasive, recurrent odontogenic tumor.
- Histological diagnosis can be challenging due to variable features like high mitosis and neural invasion.
- It is a rare benign neoplasia that can exhibit malignant behavior.
Purpose of the Study:
- To review immunohistochemical markers associated with ameloblastoma.
- To explore markers related to molecular pathways, bone remodeling, proliferation, apoptosis, signaling, and tumor suppression.
- To aid in diagnosis, prognosis, and treatment strategy development.
Main Methods:
- Literature review of immunohistochemical markers in ameloblastoma.
- Analysis of marker associations with clinical signs and biological behavior.
- Focus on markers in specific molecular pathways.
Main Results:
- Certain immunohistochemical markers are associated with ameloblastoma epithelium.
- These markers can assist in differentiating ameloblastoma from other lesions.
- Marker identification is crucial for understanding tumor behavior.
Conclusions:
- Immunohistochemical markers are valuable tools for ameloblastoma diagnosis and prognosis.
- Targeted therapies based on marker profiles can improve treatment efficacy.
- Further research into these markers can enhance patient quality of life.
